LY-2886721

DB12547InvestigationalSmall molecule

LY2886721 has been used in trials studying the basic science of Alzheimer's Disease.

Chemical structure of LY-2886721
Mechanism
Curator reviewed
Formula / weight
C18H16F2N4O2S · 390.41 g/mol (avg)
Code names
LY2886721

Resolves to

Compound
UNII2CQ62IWB67CAS1262036-50-9ChEMBLCHEMBL2396989PubChem49837968
Structure
InChIKeyNIDRNVHMMDAAIK-YPMLDQLKSA-NSMILESNC1=N[C@]2(COC[C@H]2CS1)C1=C(F)C=CC(NC(=O)C2=CC=C(F)C=N2)=C1
Targets
P56817BACE1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-2886721, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In